Clinical Trial Update: Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus (HIV) Patients

View source ↗

Summary

This clinical trial update reports on the safety and efficacy of delavirdine (Rescriptor) in HIV infection. The study is completed and results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Rescriptor (delavirdine)

Snippet

Sponsor: Pfizer | Conditions: HIV-1 Infection | Status: COMPLETED | Results posted: 2010-07-05